Sojo-Dorado J., López-Hernández I., Hernández-Torres A., Retamar-Gentil P., Merino De Lucas E., Escolà-Verge L., Bereciartua E., García-Vázquez E., Pintado V., Boix-Palop L., Natera-Kindelán C., Sorlí L., Borrell N., Amador-Prous C., Shaw E., Jover-Saenz A., Molina J., Martínez-Álvarez R.M., Dueñas C.J., Calvo-Montes J., Lecuona M., Pomar V., Borreguero I., Palomo-Jimenez V., Docobo-Perez F., Pascual Á., Rodríguez-Baño J.. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023; 78(7)DOI:10.1093/jac/dkad147. PMID:37260299. IF:3.900(Q1/3D).

de Mendoza C., Carrizo P., Sauleda S., Richart A., Rando A., Miró E., Benito R., Ayerdi O., Encinas B., Aguilera A., Reina G., Rojo S., González R., Fernández-Ruiz M., Liendo P., Montiel N., Roc L., Treviño A., Pozuelo M.J., Soriano V.. The slowdown of new infections by human retroviruses has reached a plateau in Spain. JOURNAL OF MEDICAL VIROLOGY. 2023; 95(5)DOI:10.1002/jmv.28779. PMID:37212269. IF:6.800(Q1/1D).

Pérez-Recio S., Grijota-Camino M.D., Anibarro L., Rabuñal-Rey R., Sabria J., Gijón-Vidaurreta P., Pomar V., García-Gasalla M., Domínguez-Castellano Á., Trigo M., Santos M.J., Cebollero A., Rodríguez S., Moga E., Penas-Truque A., Martos C., Ruiz-Serrano M.J., Garcia-De-Cara E.I., Alcaide F., Santin M.. Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study. PLoS One. 2023; 18(8)DOI:10.1371/journal.pone.0285917. PMID:37647315. IF:2.900(Q1/3D).

Batlle M., Badia J.M., Hernández S., Grau S., Padulles A., Boix-Palop L., Giménez-Pérez M., Ferrer R., Calbo E., Limón E., Pujol M., Horcajada J.P., Smithson A., Ros N.B., Gomila-Grange A., Pomar V., Toboso S.H., Murgadella-Sancho A., Perez-Hita A.O., Temple M.D., Molpeceres S.V., Pardo D.R., Río A.D., Luque M.F.S., Blanco N.V., Acedo S.O., Guitart S.S., Nicolas E.M., Noblia-Gigena L.B., Pérez O.D.R., Rodriguez M.P.G., Barcons I.A., Serra N.J., Calva L.C., Lérida A., Torras S.G., Martínez L.H., Miñambres C., Matellane J.M., Jofre C.S., Estada S.B., Carrascosa M.C., Mota S.T., Barrena D.S.. Reducing the duration of antibiotic therapy in surgical patients through a specific nationwide antimicrobial stewardship program. A prospective, interventional cohort study. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023; 62(5)DOI:10.1016/j.ijantimicag.2023.106943. PMID:37541529. IF:4.900(Q1/2D).